Hypoxia-related biological markers as predictors of epirubicin-based treatment responsiveness and resistance in locally advanced breast cancer

PURPOSE: To identify hypoxia-related biomarkers indicative of response and resistance to epirubicin treatment in patients with locally advanced breast cancer. PATIENTS AND METHODS: One hundred seventy-six women with T2-4 N0-1 breast tumours were randomly assigned to receive epirubicin 120 mg/m2/1-21...

Descripción completa

Detalles Bibliográficos
Autores principales: Milani, Manuela, Venturini, Sergio, Bonardi, Simone, Allevi, Giovanni, Strina, Carla, Cappelletti, Maria Rosa, Corona, Silvia Paola, Aguggini, Sergio, Bottini, Alberto, Berruti, Alfredo, Jubb, Adrian, Campo, Leticia, Harris, Adrian L., Gatter, Kevin, Fox, Stephen B., Generali, Daniele, Roviello, Giandomenico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668004/
https://www.ncbi.nlm.nih.gov/pubmed/29108271
http://dx.doi.org/10.18632/oncotarget.20239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668004/
https://www.ncbi.nlm.nih.gov/pubmed/29108271
http://dx.doi.org/10.18632/oncotarget.20239

Ejemplares similares